EGF Theramed Health Corp.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TMED.CN research report →
Companywww.egftheramedhealth.com
EGF Theramed Health Corp. provides psychedelic drugs for the treatment of mental health. It offers psychedelics for the treatment of conditions, such as treatment-resistant depression, anxiety, PTSD, and depression.
- CEO
- Connor Yuen
- IPO
- 2013
- HQ
- Vancouver, BC, CA
Price Chart
Valuation
- Market Cap
- $929.33K
- P/E
- -0.45
- P/S
- 0.00
- P/B
- -0.31
- EV/EBITDA
- -1.44
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 78.43%
- ROIC
- 3.81%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-3,206,161 · -1090.76%
- EPS
- $-0.28 · -1066.67%
- Op Income
- $-274,497
- FCF YoY
- 122.08%
Performance & Tape
- 52W High
- $0.13
- 52W Low
- $0.06
- 50D MA
- $0.06
- 200D MA
- $0.08
- Beta
- 0.29
- Avg Volume
- 1.32K
Get TickerSpark's AI analysis on TMED.CN
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our TMED.CN Coverage
We haven't published any research on TMED.CN yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate TMED.CN Report →